<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for JNJ</title>
    <link />
    <description>Headlines for Johnson &amp; Johnson</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Johnson &amp; Johnson: Aragon Pharmaceuticals Is An Excellent Addition For Its Oncology Unit</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1509952-johnson-johnson-aragon-pharmaceuticals-is-an-excellent-addition-for-its-oncology-unit.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 19 Jun 2013 09:02:12 GMT</pubDate>
    </item>
    <item>
      <title>The Top 3 Medical Uses of Botox</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/18/the-top-3-medical-uses-of-botox/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 18 Jun 2013 19:20:00 GMT</pubDate>
    </item>
    <item>
      <title>One Simple Measure for Investing in a Volatile Market</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/vix/articles/192058/one-simple-measure-for-investing-in-a-volatile-market/2013-06-18.aspx</link>
      <author>Trefis</author>
      <pubDate>Tue, 18 Jun 2013 17:32:33 GMT</pubDate>
    </item>
    <item>
      <title>J&amp;J to Buy Aragon for $1 Billion  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101787/jj-to-buy-aragon-for-$1-billion.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 18 Jun 2013 15:50:01 GMT</pubDate>
    </item>
    <item>
      <title>The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter)</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/18/fda-might-pull-this-drug-from-the-market-and-why-i/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 18 Jun 2013 15:16:00 GMT</pubDate>
    </item>
    <item>
      <title>An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1508122-an-interview-with-elemer-piros-a-strong-year-for-biotechs-looking-from-the-halfway-point.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 18 Jun 2013 11:34:22 GMT</pubDate>
    </item>
    <item>
      <title>Johnson &amp; Johnson Gets Key Cancer Drug With Aragon Buy</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11953596/1/johnson-johnson-gets-key-cancer-drug-with-aragon-buy.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 18 Jun 2013 11:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Buy-Rated Dow Components Slip To Ten</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11953023/1/buy-rated-dow-components-slips-to-ten.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 18 Jun 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Merger Monday: 2 Blue Chips Making Smart Buys</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/merger-monday-2-blue-chips-making-smart-buys/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 19:18:00 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's M&amp;A Chatter for Monday June 17, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3682763/benzingas-m-a-chatter-for-monday-june-17-2013.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Jun 2013 17:33:58 GMT</pubDate>
    </item>
    <item>
      <title>Johnson &amp; Johnson And Aragon May Have Medivation Feeling Sick</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1506592-johnson-johnson-and-aragon-may-have-medivation-feeling-sick.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 17:17:40 GMT</pubDate>
    </item>
    <item>
      <title>Why Medivation Shares Retreated</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/why-medivation-shares-retreated/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 16:21:00 GMT</pubDate>
    </item>
    <item>
      <title>Company News for June 17, 2013 - Corporate Summary</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/101660/company-news-for-june-17-2013.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 17 Jun 2013 14:06:01 GMT</pubDate>
    </item>
    <item>
      <title>American Generics Can't Touch This $8 Billion Drug (Yet)</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/american-generics-cant-touch-this-8-billion-drug-y/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 13:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Don't Count Out Dividend Stocks Just Yet</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1505942-don-t-count-out-dividend-stocks-just-yet.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 13:37:22 GMT</pubDate>
    </item>
    <item>
      <title>Johnson &amp; Johnson to Buy Aragon Pharmaceuticals for $650 Million Up Front</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/06/17/johnson-johnson-to-buy-aragon-pharmaceuticals-for/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 17 Jun 2013 13:12:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Raising The Drugs Industry Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11952402/1/5-stocks-raising-the-drugs-industry-higher.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 17 Jun 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE 1-J&amp;J, in new $1 bln deal, bolsters prostate-cancer role</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/idusl2n0et0ey20130617.aspx</link>
      <author>Reuters</author>
      <pubDate>Mon, 17 Jun 2013 11:32:56 GMT</pubDate>
    </item>
    <item>
      <title>Boston Scientific: Upside Scenario To Our Estimates</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/bsx/articles/191363/boston-scientific-upside-scenario-to-our-estimates/2013-06-14.aspx</link>
      <author>Trefis</author>
      <pubDate>Mon, 17 Jun 2013 09:39:10 GMT</pubDate>
    </item>
    <item>
      <title>J&amp;J to Acquire Privately Held Aragon Pharma</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130617-000141&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 17 Jun 2013 08:54:59 GMT</pubDate>
    </item>
  </channel>
</rss>
